Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VER-01 vs Beriplast P as Adjunct to Cranial Dural Closure
jRCT2031230364Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of VER-01 in cerebrospinal fluid leak, Pseudomeningocele and None (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Incidence of postoperative CSF leak or pseudomeningocele within 7 days. Started Oct 2023; status: completed.
02
Drugs
VER-01
03
Conditions
cerebrospinal fluid leakPseudomeningocele
Beyond the preview
Go deeper on jRCT2031230364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230364.